Phase II Dose Confirmed and Encouraging Survival Data
Midatech Pharma PLC (MTPH.L) Headline Results of MTX110 Phase I DIPG Study
TPI provides its latest research note on Midatech Pharma plc (MTPH.L).
Midatech has today announced encouraging headline results from a Phase I study at the University of California, San Francisco (‘UCSF’) in patients with the orphan condition, Diffuse Intrinsic Pontine Glioma
TPI provides its latest research note on Midatech Pharma plc (MTPH.L).
Midatech has today announced its signing of further research collaboration, this time with an unnamed ‘global pharmaceutical’ group that wishes to utilise its Q-Sphera™ platform in order to improve/optimise the
Midatech Pharma PLC (MTPH.L) Collaboration for the Q-Sphera platform
Midatech Pharma’s next generation drug delivery technologies to be applied to new modalities in collaboration with a European pharmaceutical company.
